Shares of Bausch Health, formerly Valeant, rise 3% on FDA approval of psoriasis treatment - CNBC https://t.co/Pp18nDdDtF
— IDRO (@IDROOhio) April 26, 2019
from Twitter https://twitter.com/IDROOhio
April 26, 2019 at 01:35AM
Friday, April 26, 2019
Shares of Bausch Health, formerly Valeant, rise 3% on FDA approval of psoriasis treatment - CNBC https://t.co/Pp18nDdDtF
from Twitter https://twitter.com/IDROOhio
April 26, 2019 at 01:35AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment